Research demonstrates SNO-COX-2 expression correlates with mesenchymal traits in early-stage breast cancer, suggesting inflammation's role in tumor behavior.
Key Points
SNO-COX-2 expression is closely linked to mesenchymal phenotypes in MCF10DCIS cells.
Non-nitrosylated COX-2 does not show strong association with invasive tumor features in this model.
Increased SNO-COX-2 levels are influenced by specific tumor microenvironment conditions.
SNO-COX-2 shows potential utility as a biomarker for assessing breast cancer progression risk.